Anne-sophie S. Dieudonne
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 13, 2017
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects.
Journal: Breast cancer research and treatment
Published: June 12, 2015
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
Journal: Breast cancer research and treatment
Published: May 18, 2015
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.
Journal: Breast cancer research and treatment
Published: June 09, 2014
How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?
Journal: Acta clinica Belgica
Published: March 19, 2014
Why should results from metastatic trials no longer matter for early-stage disease?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 19, 2013
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 12, 2013
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 06, 2012
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency.
Journal: Carcinogenesis
Published: May 25, 2012
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Journal: Nature genetics
Published: May 14, 2012
The role of genetic breast cancer susceptibility variants as prognostic factors.
Journal: Human molecular genetics
Published: April 26, 2012
Last Updated: 09/26/2026